Cahill Represents Lead Arrangers of New Capsugel Credit Facilities
Cahill represented UBS and the other lead arrangers in connection with a new €355 million term loan and a $25 million increase in the company’s revolving credit facility. Capsugel is a leading company in the healthcare space, providing innovative dosage solutions to clients at every stage of the dosage form development process. Capsugel is a portfolio company of KKR. This complex international transaction involved collateral and guarantees in Australia, Belgium, Brazil, Canada, France, Hong Kong, Indonesia, Japan, Luxembourg, Mexico, New Zealand and the United Kingdom in addition to the United States.